Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tencent Co-Leads $67 Million Financing for UK's Microbiotica

publication date: Mar 8, 2022

Microbiotica, a UK microbiome drug company, completed a $67 million B Financing co-led by China's Tencent and Flerie Invest, a Swedish life science investor. Although Tencent is primarily an internet company, it also delivers healthcare in China through its portal WeDoctor and has shown interest in novel drug technologies. Microbiotica will use the proceeds to conduct Phase Ib trials of its two lead oral Live Bacterial Therapeutics. MB097 is a predictive test of a patient's response to immune checkpoint drugs, and MB310 is aimed at treating ulcerative colitis via a fecal transplant. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital